Evidence map›Paper›PMID 39110436›Full record

Trial reportJAMA2024

A Vaping Cessation Text Message Program for Adolescent E-Cigarette Users: A Randomized Clinical Trial.

Amanda L Graham, Sarah Cha, Megan A Jacobs, Michael S Amato, Anna L Funsten, Giselle Edwards, George D Papandonatos

Erratum issued Registry-linked trialAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in JAMA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04919590 (Text Message Quit Vaping Intervention for Adolescents), which is not on this map. Cited by 37 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04919590 nacompletednot on this map

Text Message Quit Vaping Intervention for Adolescents

TypeinterventionalSponsorTruth InitiativeRan2021 to 2023Enrolled1,681ConditionsVaping, Cessation, TobaccoArmsThis is Quitting, Assessment only control, Waitlist control
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Interventions for quitting vaping.The Cochrane database of systematic reviews · 2025
    Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. The feasibility and acceptability of Live Free From E-Cigarettes (LIFFE): A web-based vaping intervention and smoking prevention program for young adults.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Amanda L GrahamInnovations Center, Truth Initiative, Washington, DC.
Sarah ChaInnovations Center, Truth Initiative, Washington, DC.
Megan A JacobsInnovations Center, Truth Initiative, Washington, DC.
Michael S AmatoInnovations Center, Truth Initiative, Washington, DC.
Anna L FunstenInnovations Center, Truth Initiative, Washington, DC.
Giselle EdwardsInnovations Center, Truth Initiative, Washington, DC.
George D PapandonatosCenter for Statistical Sciences, Brown University, Providence, Rhode Island.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: E-cigarettes are the most commonly used tobacco product among adolescents. Despite known harms of nicotine exposure among teens, there are no empirically tested vaping cessation interventions. Objective: To compare the effectiveness of a text message program for nicotine vaping cessation among adolescents with assessment-only control. Design, Setting, and Participants: A parallel, 2-group, double-blind, individually randomized clinical trial with follow-ups at 1 and 7 months after randomization was conducted from October 1, 2021, to October 18, 2023. Participants were recruited via social media ads; the intervention was delivered via text message; and assessments were completed online or by telephone. Eligible individuals were US residents aged 13 to 17 years who reported past 30-day e-cigarette use, were interested in quitting within 30 days, and owned a mobile phone with an active text message plan. To optimize study retention, all participants received monthly assessments via text message about e-cigarette use. Interventions: Assessment-only controls (n = 744) received only study retention text messages. Intervention participants (n = 759) also received an automated, interactive text message program for vaping cessation that delivers cognitive and behavioral coping skills training and social support. Main Outcomes and Measures: The primary outcome was self-reported 30-day point-prevalence abstinence from vaping at 7 months analyzed as intention-to-treat, with missingness coded as vaping. Results: Among n = 1503 adolescents randomized, average age was 16.4 (SD, 0.8) years. The sample was 50.6% female, 42.1% male, and 7.4% nonbinary/other; 10.2% Black/African American, 62.6% White, 18.5% multiracial, and 8.7% another race; 16.2% Hispanic; 42.5% sexual minority; and 76.2% vaped within 30 minutes of waking. The 7-month follow-up rate was 70.8%. Point-prevalence abstinence rates were 37.8% (95% CI, 34.4%-41.3%) among intervention participants and 28.0% (95% CI, 24.9%-31.3%) among control participants (relative risk, 1.35 [95% CI, 1.17-1.57]; P < .001). No baseline variables moderated the treatment-outcome relationship. There was no evidence that adolescents who quit vaping transitioned to combustible tobacco products. Conclusions and Relevance: A tailored, interactive text message intervention increased self-reported vaping cessation rates among adolescents recruited via social media channels. Trial Registration: ClinicalTrials.gov Identifier: NCT04919590.

Indexed as

Electronic Nicotine Delivery SystemsSmoking CessationText MessagingVapingAdolescentDouble-Blind MethodFemaleHumansMalePrevalenceSelf ReportUnited States

Identifiers

PMID39110436
PMCPMC11307165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.